Biblio
“Midlife Physical Activity and Cognition Later in Life: A Prospective Twin Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1303-1317, 2016.
, “Mild Cognitive Impairment and Susceptibility to Scams in Old Age.”, J Alzheimers Dis, vol. 49, no. 3, pp. 845-51, 2016.
, “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
, “Mindfulness Training for Older Adults with Subjective Cognitive Decline: Results from a Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 2, pp. 757-74, 2016.
, “Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 487-96, 2016.
, “miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
, “Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1405-10, 2016.
, “"Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria.”, J Alzheimers Dis, vol. 52, no. 2, pp. 685-91, 2016.
, “Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1257-70, 2016.
, “A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.”, J Alzheimers Dis, vol. 50, no. 1, pp. 201-15, 2016.
, “Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
, “Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 53, no. 2, pp. 677-91, 2016.
, “Modulation of miR-19 in Aluminum-Induced Neural Cell Apoptosis.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1149-62, 2016.
, “Molecular markers of amnestic mild cognitive impairment among Mexican Americans.”, J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
, “Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 335-52, 2016.
, “Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.”, J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.
, “Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1189-202, 2016.
, “Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.”, J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
, “Mortality in Mild Cognitive Impairment: A Longitudinal Study in Memory Clinics.”, J Alzheimers Dis, vol. 54, no. 1, pp. 149-55, 2016.
, “Motoric Cognitive Risk Syndrome and Falls Risk: A Multi-Center Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1043-52, 2016.
, “Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1209-30, 2016.
, “Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.”, J Alzheimers Dis, vol. 50, no. 1, pp. 175-88, 2016.
, “Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.”, J Alzheimers Dis, vol. 54, no. 1, pp. 359-71, 2016.
, “Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1035-50, 2016.
, “The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1475-84, 2016.
,